Jiangsu Hansoh Pharmaceutical Co., Ltd.
37 active trials across 8 therapeutic areas
37
Active Trials
27
Phase 1
6
Phase 2
6
Phase 3
8
Therapeutic Areas
Portfolio Concentration: 92% of active trials in Oncology
Oncology
34 active / 35 total
NSCLC
11 active
3 Ph3
11 total since 2015
Solid Tumor (Advanced)
6 active
7 total since 2015
CML
3 active
3 total since 2015
Renal Cell Carcinoma
2 active
2 total since 2015
Ovarian Cancer
2 active
2 total since 2015
Breast Cancer
2 active
2 total since 2015
Colorectal Cancer
2 active
2 total since 2015
Lung Cancer (General)
1 active
1 total since 2015
Triple Negative Breast Cancer
1 active
1 total since 2015
Prostate Cancer
1 active
1 total since 2015
Gastric Cancer
1 active
1 total since 2015
Pancreatic Cancer
1 active
1 total since 2015
SCLC
1 active
1 total since 2015
Metabolic
5 active / 8 total
Immunology
2 active / 3 total
Infectious Disease
1 active / 2 total
Women's Health
1 active / 1 total
CNS
0 active / 2 total
Musculoskeletal
0 active / 1 total
Renal
0 active / 1 total
Click an indication to see competitive landscape (all sponsors in that indication).
Data: ClinicalTrials.gov (2015+)